247 related articles for article (PubMed ID: 24144388)
1. Toward an understanding of agonist binding to human Orexin-1 and Orexin-2 receptors with G-protein-coupled receptor modeling and site-directed mutagenesis.
Heifetz A; Barker O; Morris GB; Law RJ; Slack M; Biggin PC
Biochemistry; 2013 Nov; 52(46):8246-60. PubMed ID: 24144388
[TBL] [Abstract][Full Text] [Related]
2. Study of human Orexin-1 and -2 G-protein-coupled receptors with novel and published antagonists by modeling, molecular dynamics simulations, and site-directed mutagenesis.
Heifetz A; Morris GB; Biggin PC; Barker O; Fryatt T; Bentley J; Hallett D; Manikowski D; Pal S; Reifegerste R; Slack M; Law R
Biochemistry; 2012 Apr; 51(15):3178-97. PubMed ID: 22448975
[TBL] [Abstract][Full Text] [Related]
3. Dynein light chain Tctex-type 1 modulates orexin signaling through its interaction with orexin 1 receptor.
Duguay D; Bélanger-Nelson E; Mongrain V; Beben A; Khatchadourian A; Cermakian N
PLoS One; 2011; 6(10):e26430. PubMed ID: 22028875
[TBL] [Abstract][Full Text] [Related]
4. Expression of orexin B and its receptor 2 in rat testis.
Liguori G; Pavone LM; Assisi L; Langella E; Tafuri S; Mirabella N; Costagliola A; Vittoria A
Gen Comp Endocrinol; 2017 Feb; 242():66-73. PubMed ID: 26631456
[TBL] [Abstract][Full Text] [Related]
5. Orexins modulate the growth of cultured rat adrenocortical cells, acting through type 1 and type 2 receptors coupled to the MAPK p42/p44- and p38-dependent cascades.
Spinazzi R; Ziolkowska A; Neri G; Nowak M; Rebuffat P; Nussdorfer GG; Andreis PG; Malendowicz LK
Int J Mol Med; 2005 May; 15(5):847-52. PubMed ID: 15806308
[TBL] [Abstract][Full Text] [Related]
6. Intramolecular fluorescence resonance energy transfer (FRET) sensors of the orexin OX1 and OX2 receptors identify slow kinetics of agonist activation.
Xu TR; Ward RJ; Pediani JD; Milligan G
J Biol Chem; 2012 Apr; 287(18):14937-49. PubMed ID: 22389503
[TBL] [Abstract][Full Text] [Related]
7. Orexin receptors: pharmacology and therapeutic opportunities.
Scammell TE; Winrow CJ
Annu Rev Pharmacol Toxicol; 2011; 51():243-66. PubMed ID: 21034217
[TBL] [Abstract][Full Text] [Related]
8. The SK-N-MC cell line expresses an orexin binding site different from recombinant orexin 1-type receptor.
Wieland HA; Söll RM; Doods HN; Stenkamp D; Hurnaus R; Lämmle B; Beck-Sickinger AG
Eur J Biochem; 2002 Feb; 269(4):1128-35. PubMed ID: 11856342
[TBL] [Abstract][Full Text] [Related]
9. Targeting orexin receptors: Recent advances in the development of subtype selective or dual ligands for the treatment of neuropsychiatric disorders.
Bonifazi A; Del Bello F; Giorgioni G; Piergentili A; Saab E; Botticelli L; Cifani C; Micioni Di Bonaventura E; Micioni Di Bonaventura MV; Quaglia W
Med Res Rev; 2023 Sep; 43(5):1607-1667. PubMed ID: 37036052
[TBL] [Abstract][Full Text] [Related]
10. Orexin A and B in vitro modify orexins receptors expression and gonadotropins secretion of anterior pituitary cells of proestrous rats.
Cataldi NI; Lux Lantos VA; Libertun C
Regul Pept; 2014 Jan; 188():25-30. PubMed ID: 24333629
[TBL] [Abstract][Full Text] [Related]
11. Modeling of the OX1R-orexin-A complex suggests two alternative binding modes.
Karhu L; Turku A; Xhaard H
BMC Struct Biol; 2015 May; 15():9. PubMed ID: 25957175
[TBL] [Abstract][Full Text] [Related]
12. Orexins excite neurons of the rat cerebellar nucleus interpositus via orexin 2 receptors in vitro.
Yu L; Zhang XY; Zhang J; Zhu JN; Wang JJ
Cerebellum; 2010 Mar; 9(1):88-95. PubMed ID: 19921532
[TBL] [Abstract][Full Text] [Related]
13. Selective orexin receptor antagonists.
Lebold TP; Bonaventure P; Shireman BT
Bioorg Med Chem Lett; 2013 Sep; 23(17):4761-9. PubMed ID: 23891187
[TBL] [Abstract][Full Text] [Related]
14. Orexins/hypocretins acting at Gi protein-coupled OX 2 receptors inhibit cyclic AMP synthesis in the primary neuronal cultures.
Urbańska A; Sokołowska P; Woldan-Tambor A; Biegańska K; Brix B; Jöhren O; Namiecińska M; Zawilska JB
J Mol Neurosci; 2012 Jan; 46(1):10-7. PubMed ID: 21547533
[TBL] [Abstract][Full Text] [Related]
15. High specificity of human orexin receptors for orexins over neuropeptide Y and other neuropeptides.
Holmqvist T; Akerman KE; Kukkonen JP
Neurosci Lett; 2001 Jun; 305(3):177-80. PubMed ID: 11403934
[TBL] [Abstract][Full Text] [Related]
16. Mapping the binding pocket of dual antagonist almorexant to human orexin 1 and orexin 2 receptors: comparison with the selective OX1 antagonist SB-674042 and the selective OX2 antagonist N-ethyl-2-[(6-methoxy-pyridin-3-yl)-(toluene-2-sulfonyl)-amino]-N-pyridin-3-ylmethyl-acetamide (EMPA).
Malherbe P; Roche O; Marcuz A; Kratzeisen C; Wettstein JG; Bissantz C
Mol Pharmacol; 2010 Jul; 78(1):81-93. PubMed ID: 20404073
[TBL] [Abstract][Full Text] [Related]
17. Orexins stimulate glucocorticoid secretion from cultured rat and human adrenocortical cells, exclusively acting via the OX1 receptor.
Ziolkowska A; Spinazzi R; Albertin G; Nowak M; Malendowicz LK; Tortorella C; Nussdorfer GG
J Steroid Biochem Mol Biol; 2005 Sep; 96(5):423-9. PubMed ID: 16157481
[TBL] [Abstract][Full Text] [Related]
18. Orexin-A is composed of a highly conserved C-terminal and a specific, hydrophilic N-terminal region, revealing the structural basis of specific recognition by the orexin-1 receptor.
Takai T; Takaya T; Nakano M; Akutsu H; Nakagawa A; Aimoto S; Nagai K; Ikegami T
J Pept Sci; 2006 Jul; 12(7):443-54. PubMed ID: 16429482
[TBL] [Abstract][Full Text] [Related]
19. Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition.
Ho YC; Lee HJ; Tung LW; Liao YY; Fu SY; Teng SF; Liao HT; Mackie K; Chiou LC
J Neurosci; 2011 Oct; 31(41):14600-10. PubMed ID: 21994376
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of orexin receptor-arrestin-ubiquitin complex formation.
Jaeger WC; Seeber RM; Eidne KA; Pfleger KD
Br J Pharmacol; 2014 Jan; 171(2):364-74. PubMed ID: 24206104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]